Cargando…
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Ultra-long-acting integrase strand transfer inhibitors were created by screening a library of monomeric and dimeric dolutegravir (DTG) prodrug nanoformulations. This led to an 18-carbon chain modified ester prodrug nanocrystal (coined NM2DTG) with the potential to sustain yearly dosing. Here, we sho...
Autores principales: | Deodhar, Suyash, Sillman, Brady, Bade, Aditya N., Avedissian, Sean N., Podany, Anthony T., McMillan, JoEllyn M., Gautam, Nagsen, Hanson, Brandon, Dyavar Shetty, Bhagya L., Szlachetka, Adam, Johnston, Morgan, Thurman, Michellie, Munt, Daniel J., Dash, Alekha K., Markovic, Milica, Dahan, Arik, Alnouti, Yazen, Yazdi, Alborz, Kevadiya, Bhavesh D., Byrareddy, Siddappa N., Cohen, Samuel M., Edagwa, Benson, Gendelman, Howard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184486/ https://www.ncbi.nlm.nih.gov/pubmed/35680875 http://dx.doi.org/10.1038/s41467-022-30902-7 |
Ejemplares similares
-
Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Cobb, Denise A., et al.
Publicado: (2021) -
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Gautam, Nagsen, et al.
Publicado: (2021) -
ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018) -
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim, Ibrahim M, et al.
Publicado: (2019) -
Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
por: McMillan, JoEllyn, et al.
Publicado: (2017)